Expression of component desmosomal proteins in uterine endometrial carcinoma and their relation to cellular differentiation

Cancer

Volumn 78, Issue 3, 1996, Pages 461-470

  Nei, Hideyuki ^a   Saito, Tsuyoshi ^a   Tobioka, Hirotoshi ^a   Itoh, Eiki ^a   Mori, Michio ^a   Kudo, Ryuichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

desmoglein; desmoplakin I and II; desmosome; endometrial carcinoma; laser scanning microscopy

Indexed keywords

CELL MEMBRANE PROTEIN; DESMOGLEIN; DESMOPLAKIN; MONOCLONAL ANTIBODY;

ARTICLE; CANCER INVASION; CELL DIFFERENTIATION; CONTROLLED STUDY; DESMOSOME; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LYMPH NODE METASTASIS; PRIORITY JOURNAL;

BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; DESMOGLEINS; DESMOPLAKINS; DESMOSOMES; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LYMPHATIC METASTASIS; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030010584     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960801)78:3<461::AID-CNCR13>3.0.CO;2-X     Document Type: Article

References (31)

1. Moll R, Cowin P, Kapprell HP, Franke WW. Desmosomal proteins: new markers for identification and classification of tumors. Lab Invest 1986;54:4-25.
2. Brabant G, Hoang-Vu C, Cetin Y, Dralle H, Scheumann G, Moine I, et al. E-Cadherin: a differentiation marker in thyroid malignancies. Cancer Res 1993;53:4987-93.
3. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-701.
4. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HFM, Oosterhof GON, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994; 54:3929-33.
5. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, et al. E-Cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53:1690-5.
6. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991;139:17-23.
7. Schipper JH, Fixen UH, Behrens J, Unger A, Jahncke K, Birchmeier W. E-Cadherin expression in squamous cell carcinoma of head and neck: invasive correlation with tumor differentiation and lymph node metastasis. Cancer Res 1991;51:6328-37.
8. Shimoyama Y, Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 1991;51:2185-92.
9. Shimoyama Y, Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett 1991;57:131-5.
10. Inoue M, Ogawa H, Miyata M, Shiozaki H, Tanizawa O. Expression of E-cadherin in normal, benign, and malignant tissue of female genital organs. Am J Clin Pathol 1992;98:76-80.
11. Matsui S, Shiozaki H, Inoue M, Tamura S, Doki Y, Kadowaki T, et al. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer, Virchows Archiv 1994; 424:375-81.
12. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, et al. E-Cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res 1994;54:291-6.
13. Watabe M, Nagafuchi A, Tsukita S, Takeichi M. Induction of polarized cell-cell association and retardation of growth by activation of E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 1994;127:247-56.
14. Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y, et al. Somatic mutation of APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992;1:559-63.
15. Pasdar M, Nelson WJ. Kinetics of desmosome assembly in Madin-Darby canine kidney epithelial cells: temporal and spatial regulation of desmoplakin organization and stabilization upon cell-cell contact. II. Morphological analysis. J Cell Biol 1988;106:687-95.
16. Koch PJ, Walsh MJ, Schmelz M, Goldschmidt MD, Zimbelmann R, Franke WW. Identification of desmoglein, a constitutive desmosomal glycoplotein, as a marker of the cadherin family of cell adhesion molecules. Eur J Cell Biol 1990;53:1-12.
17. Stappenbeck TS, Green KJ. The desmoplakin carboxyl terminus coaligns with and specifically disrupts intermediate filament networks when expressed in cultured cells. J Cell Biol 1992;116:1197-209.
18. Parker AE, Wheeler GN, Arnemann J, Pidsley SC, Ataliotis P, Thomas CL, et al. Desmosomal glycoploteins II and III. Cadherin-like junctional molecules generated by alternative splicing. J Biol Chem 1991;266:10438-45.
19. Mechanic S, Raynor K, Hill JE, Cowin P. Desmocollins form a distinct subset of the cadherin family of cell adhesion molecules. Proc Natl Acad Sci USA 1991;88:4476-80.
20. Wheeler GN, Parker AE, Thomas CL, Ataliotis P, Poynter D, Arnemann J, et al. Desmosomal glycoprotein DG I, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules. Proc Natl Acad Sci USA 1991;88:4796-800.
21. Collins JE, Legan PK, Kenny TP, MacGarvie J, Holton JL, Garrod DR. Cloning and sequence analysis of desmosomal glycoproteins 2 and 3 (desmocollins): cadherin-like desmosomal adhesion molecules with heterogeneous cytoplasmic domains. J Cell Biol 1991;113:381-91.
22. Koch PJ, Goldschmidt MD, Zimbelmann R, Troyanovsky R, Franke WW. Complexity and expression patterns of the desmosomal cadherins. Proc Natl Acad Sci USA 1992;89:353-7.
23. Harada T, Shinohara M, Nakamura S, Shimida M, Oka M. Immunohistochemical detection of desmosomes in oral squamous cell carcinomas: correlation with differentiation, mode of invasion and metastatic potential. Int J Oral Maxillofac Surg 1992;21:346-9.
24. World Health Organization. International histological classification of tumors. Geneva: 1969-1981. 2nd ed. Berlin: Springer-Verlag, 1988-Present.
25. Kadar N, Malfetano JH, Homesley HD. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Obstet Gynecol 1992;80:655-9.
26. Christopherson WM, Connelly PJ, Alberhasky RC. Carcinoma of endometrium: V. An analysis of prognosticators in patients with favorite subtypes and stage I disease. Cancer 1983;51:1705-9.
27. Demopoulos RI, Dubin N, Noumoff J, Blaustein A, Sommers GM. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma. Obstet Gynecol 1986; 68:245-50.
28. Creasman WT, Morrow P, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer 1987;60:2035-41.
29. Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer 1993;71:1467-70.
30. Rotman M, Aziz H, Halpern J, Schwartz D, Sohn C, Choi K. Endometrial carcinoma, influence of prognostic factors on radiation management. Cancer 1993;71:1471-9.
31. Wang D-P, Konishi I, Koshiyama M, Mandai M, Nanbu Y, Ishikawa Y, et al. Expression of c-erbB-2 protein and epidermal growth factor receptor in endometrial carcinomas, correlation with clinicopathologic and sex steroid receptor status. Cancer 1993;72:2628-37.